论文部分内容阅读
目的研究社区获得性下呼吸道感染患者采用阿奇霉素及左氧氟沙星治疗的临床效果,为社区获得性下呼吸道感染临床治疗提供理论依据。方法选择2013年5月-2015年5月诊治的176例急性社区获得性下呼吸道感染患者,将其均分为对照组88例采用左氧氟沙星治疗,观察组88例采用阿奇霉素治疗,比较两组患者的临床治疗效果,数据采用SPSS 15.0软件进行统计分析。结果观察组患者有效率为95.5%、对照组为81.8%,观察组患者的总有效率高于对照组;观察组患者退热、咳嗽、咳痰、肺部哮鸣音消失时间明显比对照组快;观察组患者不良反应发生率为6.8%、对照组为20.5%,;两组比较差异均有统计学意义(P<0.05)。结论急性社区获得性下呼吸道感染患者采用阿奇霉素治疗临床效果显著,安全性高,不良反应少,值得临床推广应用。
Objective To study the clinical efficacy of azithromycin and levofloxacin in patients with community-acquired lower respiratory tract infection, and to provide a theoretical basis for clinical treatment of community-acquired lower respiratory tract infection. Methods A total of 176 patients with acute lower respiratory tract infection were selected from May 2013 to May 2015 and divided into control group (88 cases) and levofloxacin group (88 cases). The patients in the observation group were treated with azithromycin Clinical effect, the data using SPSS 15.0 software for statistical analysis. Results The effective rate was 95.5% in the observation group and 81.8% in the control group, and the total effective rate in the observation group was higher than that in the control group. The disappearance time of fever, cough, sputum and lung wheeze in the observation group was significantly longer than that in the control group The incidence of adverse reactions was 6.8% in the observation group and 20.5% in the control group. There was significant difference between the two groups (P <0.05). Conclusion Acute community-acquired lower respiratory tract infection in patients with azithromycin treatment of significant clinical effect, high safety, fewer adverse reactions, it is worth promoting the clinical application.